During the past decade, University Hospital of Heraklion, University Pulmonology Cl conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University Hospital of Heraklion, University Pulmonology Cl" are "Idiopathic Pulmonary Fibrosis" (3 trials) and "Pulmonary Fibrosis" (1 trials). Many other conditions were trialed in "University Hospital of Heraklion, University Pulmonology Cl" in a lesser frequency.

Most popular intervention types in "University Hospital of Heraklion, University Pulmonology Cl" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Nintedanib" (2 trials) and "BIBF 1120" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital of Heraklion, University Pulmonology Cl" are 4 trials for "All" genders.

Currently, there are NaN active trials in "University Hospital of Heraklion, University Pulmonology Cl". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in University Hospital of Heraklion, University Pulmonology Cl, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital of Heraklion, University Pulmonology Cl, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".